Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Cervical Cancer
  •  Immunology
  •  Kidney Cancer
  •  Endoscopy Methods
  •  Palliative Care
  •  General Oncology
  •  Gastrointestinal Cancer
  •  Hematology

Abstract

Citation: Clin Oncol. 2017;2(1):1309.DOI: 10.25107/2474-1663.1309

Association of Oral Contraceptives and Hormone Replacement Therapy with Pancreatic Cancer Risk in Women: A Meta-Analysis

Jin-Xiao Liang, Wei Gao, Xin-ming Zhou, Yong Liang and Jun Ling

Department of Thoracic Surgery, Zhejiang Cancer Hospital, Republic of China
Department of Biochemistry and Molecular Biology, Dalian Medical University, Republic of China
Department of Clinical Medicine, Taizhou University Medical School, Republic of China
Department of Basic Sciences, Geisinger Commonwealth School of Medicine, USA

*Correspondance to: Yong Liang 

 PDF  Full Text Research Article | Open Access

Abstract:

Although the incidence rate of pancreatic cancer is higher in men than in women, Oral Contraceptives (OC) and Hormone Replacement Therapy (HRT) commonly used in women may constitute a risk or protective factor for pancreatic cancer. Some studies have examined these relationships, but no coherent conclusions have been reached. Thus, we conducted a meta-analysis in this study by extensive search of literature using PubMed and EMBASE databases. It was found that OC use was associated with the significant decrease in pancreatic cancer risk (pooled OR 0.75, 95% CI 0.61-0.91). Subgroup analysis identified that OC decreased the risk in the pancreatic cancer population-based studies (pooled OR 0.76, 95 % CI 0.67-0.86) but was controversial in the hospital-based studies (pooled OR 1.21, 95% CI 0.94-1.57). HRT did not show the significant effect on pancreatic cancer risk (pooled OR 1.00, 95 % CI 0.79-1.26). However, subgroup analysis identified the decreased risk in North America population (pooled OR 0.81, 95% CI 0.65-1.01) but the increased risk in Europe population (pooled OR 1.51, 95% CI 1.16-1.97). In conclusion, OC use was demonstrated to have a protective effect against pancreatic cancer in women, where as HRT showed no effect or diverse effects in different populations. Our results increase the awareness of using HRT in women when considering pancreatic cancer risk. The subgroup analysis also suggests that more clinical studies are needed to clarify the specific relationship between OC or HRT and pancreatic cancer risk in different populations.

Keywords:

Pancreatic cancer; Oral contraceptives; Hormone replacement therapy; Risk factor, Meta-analysis

Cite the Article:

Liang J-X, Gao W, Zhou X-M, Liang Y, Ling J. Association of Oral Contraceptives and Hormone Replacement Therapy with Pancreatic Cancer Risk in Women: A Meta- Analysis. Clin Oncol. 2017; 2: 1309.

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Gene Polymorphisms and Gene Expression Profiles as Potential Predictors of Survival Outcomes in Ovarian Cancer: Systematic Review and Meta-Analysis of Pharmacogenetic/Genomic and Microarray Data
 Abstract  PDF  Full Text
Cardiovascular Screening and Prevention in Female Breast Cancer Patients Receiving Radiotherapy
 Abstract  PDF  Full Text
View More...